SCHEMBL2406016

SCHEMBL2406016

NC(=O)c1cccc(-c2cccc(N3CCC(CCN(Cc4cscn4)C(=O)O)CC3)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
PRKD1 Q15139 1/20 0.36
PRKD2 Q9BZL6 1/20 0.36
CNR1 P21554 2/20 0.36
PIM2 Q9P1W9 1/20 0.36
FFAR4 Q5NUL3 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
FYN P06241 1/20 0.35
MTOR P42345 2/20 0.35
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
PKM P14618 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PDE10A Q9Y233 1/20 0.34
PIM1 P11309 1/20 0.34
ITGAV P06756 1/20 0.34
ITGB6 P18564 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407695 0.93 CPT2 (0.34) PRKD1PRKD2FFAR4CKS1BSKP1
SCHEMBL2408111 0.92 PRKD1 (0.37) SYKPRKD1PRKD2CNR1PIM2
SCHEMBL2411932 0.91 SMN1; SMN2 (0.43) CNR1FFAR4SMN1; SMN2FYNPDE10A
SCHEMBL2408430 0.89 CNR1 (0.42) CNR1PIM2FFAR4SMN1; SMN2RAB9A
SCHEMBL2406147 0.89 AOC3 (0.38) SMN1; SMN2FYNCKS1BSKP1SKP2
SCHEMBL2405288 0.88 CKS1B (0.41) CNR1FFAR4CKS1BSKP1SKP2
SCHEMBL2405682 0.88 KMO (0.38) CNR1FFAR4CKS1BSKP1SKP2
SCHEMBL2411876 0.88 CNR1 (0.41) CNR1PIM2FFAR4PIM1
SCHEMBL2407342 0.88 DKK1 (0.41) CNR1FFAR4SMN1; SMN2CKS1BSKP1
SCHEMBL2405737 0.87 FFAR1 (0.36) CNR1PIM2FFAR4CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912218-B2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-12-16 US disclosed
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF MET, ALK, REL SYK 476/4885PRKD1 2512/4885PRKD2 3006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.